TERBUTALINE SULFATE

Generic: TERBUTALINE SULFATE

Amneal Pharmaceuticals of New York LLCManufacturer
ORALRoute
TERBUTALINE SULFATEActive Substance
2001-06-26Original Approval

TERBUTALINE SULFATE is FDA application ANDA075877, sponsored by IMPAX LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DYSPNOEA
426 reports
2
ASTHMA
380 reports
3
WHEEZING
258 reports
4
PNEUMONIA
209 reports
5
COUGH
206 reports
6
DRUG INEFFECTIVE
153 reports
7
FATIGUE
148 reports
8
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES
142 reports
9
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
124 reports
10
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION
120 reports